Hypertensive Disease Samples

Central BioHub offers Hypertensive Disease Samples which include the diseases Essential (primary) hypertension and Hypertensive heart disease. Use our filter functions to perform complex searches according to matrices, disease in clear name or ICD-10 code, laboratory parameters, medication and patient annotation like age, gender, BMI and ethnicity. For normal control groups please switch to the category Healthy Donors. If you do not find the samples you are looking for, please contact us.

Available filters
-
-
56 Products

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 53 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
53 Years
Ethnic group:
European/Caucasian
BMI:
43 kg/m²
Weight:
125 kg
Height:
171 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E10.90
  • Mixed hyperlipidaemia [E78.2]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 150not specified)
  • Ramipril (Dosages: 10mg)
  • Sormodren (Dosages: 4mg)
  • Toujeo
  • amlodipine (Dosages: 5mg)
  • atorvastatin (Dosages: 20mg)
  • fenofibrate (Dosages: 250not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin (insulin Fiasp)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 115.30 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 0.46 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Thyrotropin (TSH)
Qual: positive
Quant: 5.95 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine (FT4)
Qual: negative
Quant: 14.10 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine (FT3)
Qual: negative
Quant: 2.90 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH273993
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 47 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Bisoprolol
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
47 Years
Ethnic group:
European/Caucasian
BMI:
53 kg/m²
Weight:
152.4 kg
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E11.90
  • I10.90
Medication:
  • Bisoprolol (Dosages: 2.5mg)
  • Desofemono
  • L-thyroxine
  • Valsartan
Therapy:
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 10.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 5.81 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170874
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Neutrophil Cytoplasmic Antibodie... - I10.9-

Donor:
Gender: Female Age: 56
Diagnosed disease:
I10.9-
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Jo-1 (a-histidyl-tRNA synthetase) Anti-Ku Anti-Mi-2 Anti-Mutated citrullinated Vimentin (MCV) Anti-Myeloperoxidase (MPO) Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Anti-OJ Protein Anti-PL-12 Anti-PL-7 ...
Donor:
Gender:
Female
Age:
56 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • I10.9-
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 42.30 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Jo-1 (a-histidyl-tRNA synthetase)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Ku
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mi-2
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Mutated citrullinated Vimentin (MCV)
Qual: negative
Quant: 1.40 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Myeloperoxidase (MPO)
Qual: negative
Quant: 1.50 U/mL
Source: this donation
< 5.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro EUROIMMUN AG
Anti-OJ Protein
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PL-12
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PL-7
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl-100
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-PM-Scl-75
Qual:
Quant: low positive
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Proteinase 3 (PR3)
Qual: negative
Quant: 0.80 U/mL
Source: this donation
< 10.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-SS-A 52 kDa (Ro 52)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Signal recognition particle (SRP)
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 20.00 IU/mL
Source: this donation
< 100 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: negative
Quant: 10.00 IU/mL
Source: this donation
< 50.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: 4.08 RU/mL
Source: this donation
< 5.00 RU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Antinuclear Antibodies (ANA)
Qual: negative
Quant: Titer
Source: this donation
Remarks: VD AMA
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: IFSprinter EUROIMMUN AG
Bone alkaline phosphatase (BAP)
Qual: positive
Quant: 31.90 µg/L
Source: this donation
5.50 - 27.10 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.94 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.47 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.32 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
EJ-Protein
Qual: negative
Quant:
Source: this donation
negative
Method: Immunoblot
System: EUROBlotMaster EUROIMMUN AG
Osteocalcin
Qual: positive
Quant: 10.20 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 38.70 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 4.6 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 2 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Serum Crosslaps
Qual: negative
Quant: 0.19 ng/mL
Source: this donation
0.14 - 1.35 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 1.10 IU/L
Source: this donation
< 1.80 IU/L
Remarks: 1,80 - 2,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: Analyzer1 EUROIMMUN AG
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH193479
1.1 mL (€123.75)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Thyrotropin (TSH) - E05.09

Donor:
Gender: Male Age: 46 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
46 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
127 kg
Height:
183 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyrotoxicosis, unspecified [E05.09]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E10.90
  • I10.90
Medication:
  • L-thyroxine (Dosages: 25not specified)
  • Lantus (active agent: insulin glargin)
  • Novorapid (active agent: insulin aspart)
  • amlodipine (Dosages: 5mg)
  • candesartan (Dosages: 32mg)
Parameter Result Ref. / Cut-Off Measuring Information
Thyrotropin (TSH)
Qual: positive
Quant: 7.60 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine (FT4)
Qual: negative
Quant: 15.80 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine (FT3)
Qual: negative
Quant: 2.90 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH244382
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Thyrotropin (TSH) - E03.09

Donor:
Gender: Female Age: 29 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Duphaston
Parameter:
Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
29 Years
Ethnic group:
European/Caucasian
BMI:
52 kg/m²
Weight:
165 kg
Height:
178 cm
Sample:
Matrix:
Serum
Condition:
slightly lipemic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.09]
  • E11.90
  • Other adrenocortical overactivity [E27.0]
  • I10.90
Medication:
  • Duphaston (Dosages: 10mg, active agent: dydrogesterone)
  • Eferox (Dosages: 125not specified)
  • Zanipress
  • loratadine
  • metformin (Dosages: 2000mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Thyrotropin (TSH)
Qual: positive
Quant: 5.07 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine (FT4)
Qual: negative
Quant: 14.40 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine (FT3)
Qual: negative
Quant: 3.70 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280003
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Male Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Metoprolol
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31 kg/m²
Weight:
95.6 kg
Height:
176 cm
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E11.90
  • I10.90
Medication:
  • Metoprolol (Dosages: 95mg)
  • Ramipril
  • amlodipine
  • hydrochlorothiazide (HCT) (Dosages: 12.5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.90 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 0.54 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 1.30 mU/L
Source: this donation
Remarks: basal
0.35 - 4.94 mU/L
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Thyrotropin (TSH)
Qual:
Quant: 5.61 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 10.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 4.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH166796
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 48 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
48 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
72 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • I10.90
  • hypertension
  • rosacea
Medication:
  • L-thyroxine (Dosages: 175not specified)
  • Ramipril
  • hydrochlorothiazide (HCT)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 2168.00 kU/L
Source: this donation
< 35.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: > 100 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual: negative
Quant: 0.92 mU/L
Source: this donation
Remarks: basal
0.35 - 4.94 mU/L
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Thyrotropin (TSH)
Qual:
Quant: 7.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 11.90 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 4.38 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH143748
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E04.9

Donor:
Gender: Female Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Euthyrox
Parameter:
Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
Gender:
Female
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
89 kg
Height:
157 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Nontoxic goitre, unspecified [E04.9]
  • E11.90
  • Postprocedural hypothyroidism [E89.0]
  • I10.90
Medication:
  • Euthyrox (specific information from donor: Euthyrox 137)
  • Metoprolol
  • candesartan (specific information from donor: candesartan 32)
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis C Virus ribonucleic acid (HCV-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: qPCR (Real-Time Quantitative PCR)
System: Cobas Ampliprep/Cobas TaqMan Roche
Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: PCR (Polymerase Chain Reaction)
System: Cobas Ampliprep/Cobas TaqMan Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165389
1 mL (€75.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Brimica
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
65.3 kg
Height:
154 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Brimica
  • Ibuflam (Dosages: 800mg/day, active agent: ibuprofen)
  • Quensyl (active agent: hydroxychloroquine)
  • Tevanate (Dosages: 70mg/week)
  • Vigantoletten (Dosages: 1000IU/day)
  • leflunomide (Dosages: 10mg/day)
  • pantoprazole (Dosages: 20mg/day)
  • salbutamol (as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.86 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 38.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252427
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Brimica
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
65.3 kg
Height:
154 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Brimica
  • Ibuflam (Dosages: 800mg/day, active agent: ibuprofen)
  • Quensyl (active agent: hydroxychloroquine)
  • Tevanate (Dosages: 70mg/week)
  • Vigantoletten (Dosages: 1000IU/day)
  • leflunomide (Dosages: 10mg/day)
  • pantoprazole (Dosages: 20mg/day)
  • salbutamol (as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.86 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 38.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252426
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Neutrophil Cytoplasmic Antibodie... - E03.9

Donor:
Gender: Female Age: 71
Diagnosed disease:
I10.90
Parameter:
25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bone-specific Alkaline Phosphatase (BAP) Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Anti-SS-A (Ro) Anti-SS-B (La) Anti-Smith (Sm) Anti-U1 small nuclear ribonucleoprotein (U1-snRNP) Anti-double-stranded DNA (dsDNA) Antinuclear Antibodies (ANA) Capsule-reactive protein (CRP) ...
Donor:
Gender:
Female
Age:
71 Years
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • I10.90
Parameter Result Ref. / Cut-Off Measuring Information
25-Hydroxy-Vitamin D3 (Calcidiol)
Qual: negative
Quant: 40.8 ng/mL
Source: this donation
30.00 - 100 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Anti-Bone-specific Alkaline Phosphatase (BAP)
Qual: negative
Quant: 12.9 µg/L
Source: this donation
5.50 - 27.10 µg/L
Remarks: sex and age dependent
Method: EIA (Enzyme Immuno Assay)
System: ISYS IDS
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro EUROIMMUN AG
Anti-SS-A (Ro)
Qual: negative
Quant: 0.6 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-SS-B (La)
Qual: negative
Quant: 1.1 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-Smith (Sm)
Qual: negative
Quant: 2.5 U/mL
Source: this donation
< 25.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-U1 small nuclear ribonucleoprotein (U1-snRNP)
Qual: negative
Quant: 1.2 U/mL
Source: this donation
< 25.00 U/mL
Remarks: 15,00 -25,00 borderline
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Anti-double-stranded DNA (dsDNA)
Qual: negative
Quant: 3.9 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Antinuclear Antibodies (ANA)
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible
negative Titer
Method: IIFT (Indirect Immunfluorescence Test)
System: iPro ORGENTEC Diagnostika GmbH
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.38 mg/L
Source: this donation
0.00 - 3.00 mg/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C3
Qual: negative
Quant: 1.1 g/L
Source: this donation
0.90 - 1.80 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Complement C4
Qual: negative
Quant: 0.29 g/L
Source: this donation
0.10 - 0.40 g/L
Method: Nephelometry
System: BN ProSpec Siemens
Osteocalcin
Qual: negative
Quant: 32.6 ng/mL
Source: this donation
10.40 - 45.60 ng/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Parathyroid hormone (PTH)
Qual: negative
Quant: 66.7 pg/mL
Source: this donation
11.50 - 78.40 pg/mL
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Rheumatoid Factor (RF) IgA
Qual: negative
Quant: 3.5 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgG
Qual: negative
Quant: 4 U/mL
Source: this donation
< 20.00 U/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
< 20.00 IU/mL
Method: ELISA (Enzyme Linked Immunosorbent Assay)
System: BEP2000 Siemens
Serum Crosslaps
Qual: negative
Quant: 0.58 ng/mL
Source: this donation
0.14 - 1.35 ng/mL
Remarks: sex and age dependent
Method: CLIA (Chemiluminescence Immuno Assay)
System: ISYS IDS
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH59701
0.6 mL (€67.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-Thyrox
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
94 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • I10.90
Medication:
  • L-Thyrox (Dosages: 200not specified)
  • Novorapid (active agent: insulin aspart)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual: positive
Quant: 1.90 U/mL
Source: previous donation
< 1.00 U/mL
Remarks: borderline: 1,00 - 1,90, positive: >= 2,00
System: LKB 147 Gamma Counter Berthold Technologies
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 179.00 kU/L
Source: previous donation
< 35.00 kU/L
System: Immulite Siemens
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: < 0.30 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH210731
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Thyroxine (FT4) - C73

Donor:
Gender: Female Age: 50 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
50 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
112 kg
Height:
166 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • C73
  • Nontoxic multinodular goitre [E04.2]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 200not specified)
  • Ramipril (Dosages: 5mg)
  • amlodipine (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Thyrotropin (TSH)
Qual: negative
Quant: < 0.01 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyroxine (FT4)
Qual: positive
Quant: 23.90 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine (FT3)
Qual: negative
Quant: 4.20 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH280013
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Olumiant
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
100 kg
Height:
162 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • methotrexate (Dosages: 7.5mg/week)
  • pantoprazole (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.57 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 13.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234433
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Olumiant
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
100 kg
Height:
162 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • methotrexate (Dosages: 7.5mg/week)
  • pantoprazole (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.57 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 13.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH234432
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Olumiant
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
100 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Olumiant (Dosages: 4mg/day, active agent: baricitinib)
  • folic acid (Dosages: 5mg/week)
  • methotrexate (Dosages: 7.5mg/week)
  • pantoprazole (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 3.57 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 13.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH282078
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Budenofalk
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
62 kg
Height:
160 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
slightly turbid
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Budenofalk (Dosages: 3mg/day, active agent: budesonide)
  • Vigantol (Dosages: 1000/day)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.16 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 47.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241246
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Budenofalk
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
62 kg
Height:
160 cm
Sample:
Matrix:
Serum
Condition:
slightly turbid
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Budenofalk (Dosages: 3mg/day, active agent: budesonide)
  • Vigantol (Dosages: 1000/day)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.16 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 47.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241245
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Erythrocyte sedimentation rate (ESR) ... - I10.90

Donor:
Gender: Female Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Budenofalk
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
62 kg
Height:
160 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
slightly turbid
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Budenofalk (Dosages: 3mg/day, active agent: budesonide)
  • Vigantol (Dosages: 1000/day)
  • Xeljanz (Dosages: 10mg/day, active agent: tofacitinib)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.16 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 47.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH241247
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
169 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg/day)
  • leflunomide (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.31 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252429
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
169 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg/day)
  • leflunomide (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.31 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252430
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Capsule-reactive protein (CRP), Eryth... - I10.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg/day)
  • leflunomide (Dosages: 20mg/day)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.31 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 18.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252428
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E74.36
  • I10.90
Medication:
  • L-thyroxine (Dosages: 75not specified)
  • Ramipril (Dosages: 5mg)
  • metformin (Dosages: 1000not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 422.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.31 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 17.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147566
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
Height:
169 cm
Sample:
Matrix:
Sodium heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E74.36
  • I10.90
Medication:
  • L-thyroxine (Dosages: 75not specified)
  • Ramipril (Dosages: 5mg)
  • metformin (Dosages: 1000not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 422.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.31 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 17.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147575
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
Height:
169 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E74.36
  • I10.90
Medication:
  • L-thyroxine (Dosages: 75not specified)
  • Ramipril (Dosages: 5mg)
  • metformin (Dosages: 1000not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 422.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.31 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 17.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147571
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
Height:
169 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E74.36
  • I10.90
Medication:
  • L-thyroxine (Dosages: 75not specified)
  • Ramipril (Dosages: 5mg)
  • metformin (Dosages: 1000not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 422.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.31 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 17.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147573
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K2EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
Height:
169 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E74.36
  • I10.90
Medication:
  • L-thyroxine (Dosages: 75not specified)
  • Ramipril (Dosages: 5mg)
  • metformin (Dosages: 1000not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 422.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.31 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 17.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 3.10 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147568
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Anti-cyclic citrullinated Peptide (CC... - I10.90

Donor:
Gender: Female Age: 84
Diagnosed disease:
I10.90
Medication:
Prednisolon
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF)
Donor:
Gender:
Female
Age:
84 Years
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • Swollen Joint Count (SJC) 3 (21.06.2016)
  • Tender Joint Count (TJC) 6 (21.06.2016)
  • Visual analogue scale (VAS) 45 mm (21.06.2016)
  • Swollen Joint Count (SJC) 3 (21.06.2016)
  • Tender Joint Count (TJC) 6 (21.06.2016)
  • Visual analogue scale (VAS) 45 mm (21.06.2016)
  • Swollen Joint Count (SJC) 3 (21.06.2016)
  • Tender Joint Count (TJC) 6 (21.06.2016)
  • Visual analogue scale (VAS) 45 mm (21.06.2016)
Diseases:
  • I10.90
Medication:
  • Prednisolon (Dosages: 5mg, active agent: glucocorticoid)
  • Quensyl (active agent: hydroxychloroquine)
  • methotrexate (Dosages: 15mg)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual:
Quant: 68.4 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Capsule-reactive protein (CRP)
Qual:
Quant: 40.9 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 30 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF)
Qual:
Quant: 174 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH251461
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3

Donor:
Gender: Female Age: 44 Ethnic group: European/Caucasian
Diagnosed disease:
I10.90
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb)
Donor:
Gender:
Female
Age:
44 Years
Ethnic group:
European/Caucasian
BMI:
46 kg/m²
Weight:
130 kg
Height:
169 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • Other disorders of intestinal carbohydrate absorption [E74.3]
  • I10.90
Medication:
  • L-thyroxine (Dosages: 50not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 75.30 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 0.48 IU/L
Source: previous donation
< 1.22 IU/L
Remarks: borderline: 1,22 - 1,75
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH252412
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - I125.5

Donor:
Gender: Male Age: 65
Diagnosed disease:
I125.5
Medication:
Moxonidin
Donor:
Gender:
Male
Age:
65 Years
BMI:
36 kg/m²
Weight:
128 kg
Height:
188 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -70 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • I125.5
  • diabetes mellitus - type 2 (not specified)
  • hypertension
  • thyroid nodes
Medication:
  • Moxonidin (Dosages: 0.2mg)
  • Simva (Dosages: 20mg)
  • Torasemid (Dosages: 10mg)
  • allopurinol (Dosages: 300mg)
  • carvedilol (Dosages: 25mg)
  • doxazosin (Dosages: 8mg)
  • valsartan (Dosages: 320mg)
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH161535
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)